Drug Design, Development and Therapy : Impact Factor & More
eISSN: 1177-8881pISSN: 1177-8881
Open AccessShare this on:
Aims and Scope of Drug Design, Development and Therapy
Drug Design, Development and Therapy is a peer-reviewed medical journal covering research on drug design and development through to clinical applications. The journal was established in 2007 and is published by Dove Medical Press. Less
Key Metrics
CiteScore 
6.6
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
1.12
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drug Design, Development and Therapy
Drug Design, Development and Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drug Design, Development and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drug Design, Development and Therapy
Postoperative Delirium After Dexmedetomidine versus Propofol Sedation in Older Adults Undergoing Hip Fracture Surgery with Spinal Anesthesia: A Randomized Controlled Trial
- 3 Aug 2026
- Drug Design, Development and Therapy
Comparison of Oliceridine and Hydromorphone for Postoperative Analgesia in Adults Undergoing Lower Limb Fracture Surgery: A Randomized Controlled Non-Inferiority Trial
- 3 Aug 2026
- Drug Design, Development and Therapy
Programmed Cell Death: A Key Mechanism of Traditional Chinese Medicine in the Treatment of Membranous Nephropathy
- 31 Jul 2026
- Drug Design, Development and Therapy
Metabolomics Reveals Potential Biomarkers for Early Detection of irAEs in ICI-Treated Patients
- 30 Jul 2026
- Drug Design, Development and Therapy
Electrophysiological Surrogates and Statistical Rigor in Dose-Response Trials: Comment on \u201cEarly Detection and Temporal Progression of Hemidiaphragmatic Paralysis After Supraclavicular Brachial Plexus Block with 20 mL vs 30 mL Ropivacaine\u201d [Letter]
- 30 Jul 2026
- Drug Design, Development and Therapy
Compound Chamomile and Lidocaine Hydrochloride Gel in Oral Diseases: A Review of Current Evidence and Potential Applications
- 30 Jul 2026
- Drug Design, Development and Therapy
Postoperative Delirium After Dexmedetomidine versus Propofol Sedation in Older Adults Undergoing Hip Fracture Surgery with Spinal Anesthesia: A Randomized Controlled Trial
- 3 Aug 2026
- Drug Design, Development and Therapy
Comparison of Oliceridine and Hydromorphone for Postoperative Analgesia in Adults Undergoing Lower Limb Fracture Surgery: A Randomized Controlled Non-Inferiority Trial
- 3 Aug 2026
- Drug Design, Development and Therapy
Programmed Cell Death: A Key Mechanism of Traditional Chinese Medicine in the Treatment of Membranous Nephropathy
- 31 Jul 2026
- Drug Design, Development and Therapy
Metabolomics Reveals Potential Biomarkers for Early Detection of irAEs in ICI-Treated Patients
- 30 Jul 2026
- Drug Design, Development and Therapy
Electrophysiological Surrogates and Statistical Rigor in Dose-Response Trials: Comment on \u201cEarly Detection and Temporal Progression of Hemidiaphragmatic Paralysis After Supraclavicular Brachial Plexus Block with 20 mL vs 30 mL Ropivacaine\u201d [Letter]
- 30 Jul 2026
- Drug Design, Development and Therapy
Compound Chamomile and Lidocaine Hydrochloride Gel in Oral Diseases: A Review of Current Evidence and Potential Applications
- 30 Jul 2026
- Drug Design, Development and Therapy
FAQs on Drug Design, Development and Therapy
How long has Drug Design, Development and Therapy been actively publishing? 
What is the publishing frequency of Drug Design, Development and Therapy?
How many articles did Drug Design, Development and Therapy publish last year?
What is the eISSN & pISSN for Drug Design, Development and Therapy?
What is Citescore for Drug Design, Development and Therapy?
What is SNIP score for Drug Design, Development and Therapy?
What is the SJR for Drug Design, Development and Therapy?
Who is the publisher of Drug Design, Development and Therapy?
